Does Rallies show 13F holders for NBP?

Yes. Rallies tracks hedge fund and 13F ownership data for NBP, including fund names, share counts, latest tracked quarter, and position changes when available.

Is NBP research on Rallies investment advice?

No. Rallies provides research, data, and educational context for NBP. It does not provide personalized investment advice.

NBP (NovaBridge Biosciences American Depositary Shares) Stock Analysis - Hedge Fund Holdings

NovaBridge Biosciences American Depositary Shares (NBP) is a publicly traded the market company. As of May 21, 2026, NBP trades at $1.79 with a market cap of $197.76M and a P/E ratio of 0.00. NBP moved +5.36% today. Year to date, NBP is -59.73%; over the trailing twelve months it is flat. Its 52-week range spans $1.67 to $5.19. Analyst consensus is buy with an average price target of $9.00. Rallies surfaces NBP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns NBP stock?

Hedge funds tracked by Rallies that own NBP include Mangrove Partners. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for NovaBridge Biosciences American Depositary Shares.

NBP Key Metrics

Key financial metrics for NBP
Metric	Value
Price	$1.79
Market Cap	$197.76M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$5.19
52-Week Low	$1.67
Volume	21.97K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Top Hedge Funds Holding NBP

Mangrove Partners holds 26.03K shares of NBP, changed +0.00% as of Dec 31, 2025.

Latest NBP News

NovaBridge Hires Mark Hagler to Drive Commercialization of Givastomig and VIS-101 — Apr 22, 2026
NovaBridge Holds $210.8M; Givastomig Targets Phase 3 in Q4 2026, VIS-101 Heads to Phase 2b in H2 2026 — Apr 7, 2026
NovaBridge Biosciences Shares Climb on >10-Letter Gains in VIS-101 Trial — Mar 9, 2026
NovaBridge’s VIS-101 Delivers >10-Letter Gains and 50% Retreatment-Free Rate at Six Months — Mar 9, 2026
NovaBridge Schedules March 9 Call to Review Phase 2a VIS-101 Data — Mar 3, 2026

Recent NBP Insider Trades

Hagler Mark Arnold bought 230.00K (~$577.30K) on Apr 24, 2026.
NORTON PIERCE sold 85 (~$4.22K) on Jan 20, 2005.
MILLER PAUL F sold 2.00K (~$97.06K) on Jan 10, 2005.

NBP Analyst Consensus

1 analysts cover NBP: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.00.

Common questions about NBP

Who owns NBP stock?: Hedge funds tracked by Rallies that own NBP include Mangrove Partners. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for NovaBridge Biosciences American Depositary Shares.
Does Rallies show 13F holders for NBP?: Yes. Rallies tracks hedge fund and 13F ownership data for NBP, including fund names, share counts, latest tracked quarter, and position changes when available.
Is NBP research on Rallies investment advice?: No. Rallies provides research, data, and educational context for NBP. It does not provide personalized investment advice.